摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 1443358-50-6

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
1443358-50-6
化学式
C70H48Br2N6Zn
mdl
——
分子量
1198.39
InChiKey
NGXBDRUVATYQIN-AOXCYIGLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Allosteric regulation of the ligand-binding ability of Zn–porphyrin by metal complexation
    摘要:
    Zn-porphyrin with bipyridyl units at the ends of a conjugated chain, in addition to two alkyl side chains, was prepared as an artificial allosteric system. The axial ligand-binding ability of the compound was considerably reduced by the formation of a Fe(bpy)(3)-type complex. The degree of the allosteric suppression strongly depended on both alkyl chain length and the steric demand of the pyridyl ligand. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2013.04.130
  • 作为产物:
    描述:
    1,3-dibromo-2-ethynylbenzene 、 5,15-bis(mesityl)-10,20-bis(4-iodophenyl)porphyrinato zinc(II)5-乙炔基-2-吡啶-2-基吡啶 在 bis-triphenylphosphine-palladium(II) chloride 、 copper(l) iodide三乙胺 作用下, 以 四氢呋喃 为溶剂, 反应 24.0h, 以41%的产率得到
    参考文献:
    名称:
    Allosteric regulation of the ligand-binding ability of Zn–porphyrin by metal complexation
    摘要:
    Zn-porphyrin with bipyridyl units at the ends of a conjugated chain, in addition to two alkyl side chains, was prepared as an artificial allosteric system. The axial ligand-binding ability of the compound was considerably reduced by the formation of a Fe(bpy)(3)-type complex. The degree of the allosteric suppression strongly depended on both alkyl chain length and the steric demand of the pyridyl ligand. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2013.04.130
点击查看最新优质反应信息

文献信息

  • Allosteric Regulation of the Ligand-Binding Ability of Zinc Porphyrins with Sterically Bulky Shielding Units by Metal Complexation
    作者:Yoshikazu Ninomiya、Masatoshi Kozaki、Shuichi Suzuki、Keiji Okada
    DOI:10.1246/bcsj.20140197
    日期:2014.11.15
    An artificial allosteric system composed of a zinc porphyrin moiety as a ligand-binding site, diphenylanthracene moieties as sterically bulky shielding units, and bipyridine terminals as Fe(II) ion-binding sites, was designed, synthesized, and characterized. The allosteric system forms an [Fe(bpy)3]-type complex in the presence of Fe(II) ions and induces a large conformational change in the alkyl side chains and shielding units, in which the anthracene groups would cover both the top and bottom of the porphyrin Zn(II) center. Consequently, the ligand-binding ability of the zinc porphyrin unit was allosterically suppressed. We found that the formation of the Fe(II) complex resulted in a 9.5-fold reduction in the binding constant between the zinc porphyrin and 3,5-bis(3,5-di-tert-butylphenyl)pyridine at 20 °C. Comparisons of entropy and enthalpy changes in the absence and presence of Fe(II) ions led to the conclusion that the allosteric suppression was mainly due to the destabilization of the Zn(II)-coordinated complex owing to the steric repulsion between the ligand and the shielding unit.
    设计、合成并表征了一种人工变构系统,该系统由卟啉部分作为配体结合位点、二苯基部分作为体积庞大的屏蔽单元、以及双吡啶末端作为Fe(II)离子结合位点组成。在存在Fe(II)离子的条件下,该变构系统形成了[Fe(bpy)3]类型的复合物,并引发了烷基侧链和屏蔽单元的巨大构象变化,其中特别是基团会覆盖卟啉Zn(II)中心的上下部分。因此,卟啉单元的配体结合能力受到变构抑制。我们发现,Fe(II)复合物的形成导致卟啉与3,5-双(3,5-二叔丁基苯基)吡啶之间的结合常数在20°C下减少了9.5倍。在缺乏和存在Fe(II)离子的情况下熵和焓变化的比较得出结论,变构抑制主要是由于配体与屏蔽单元之间的立体排斥导致Zn(II)配位复合物的不稳定性。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-